Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis

This review brings together the current knowledge regarding the risk factors and the clinical, radiologic, and histological features of both post-COVID-19 pulmonary fibrosis (PCPF) and idiopathic pulmonary fibrosis (IPF), describing the similarities and the disparities between these two diseases, us...

Descripción completa

Detalles Bibliográficos
Autores principales: Cîrjaliu, Roxana-Elena, Deacu, Mariana, Gherghișan, Ioana, Marghescu, Angela-Ștefania, Enciu, Manuela, Băltățescu, Gabriela Izabela, Nicolau, Antonela Anca, Tofolean, Doina-Ecaterina, Arghir, Oana Cristina, Fildan, Ariadna-Petronela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296314/
https://www.ncbi.nlm.nih.gov/pubmed/37371834
http://dx.doi.org/10.3390/biomedicines11061739
Descripción
Sumario:This review brings together the current knowledge regarding the risk factors and the clinical, radiologic, and histological features of both post-COVID-19 pulmonary fibrosis (PCPF) and idiopathic pulmonary fibrosis (IPF), describing the similarities and the disparities between these two diseases, using numerous databases to identify relevant articles published in English through October 2022. This review would help clinicians, pathologists, and researchers make an accurate diagnosis, which can help identify the group of patients selected for anti-fibrotic therapies and future therapeutic perspectives.

Ejemplares similares